A Phase 3 Study of the Hepcidin Mimetic Rusfertide (PTG-300) in Patients with Polycythemia Vera

Primary Objective

To evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera in maintaining hematocrit control.

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

University of Colorado Hospital

Study ID

Protocol Number: 22-0305

More information available at ClinicalTrials.gov: NCT05210790

Categories

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers